← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2003Last known activity
Aug 27, 2021
Timeline
2000s
- Jun 1, 2003
Neovii Biotech— Founded
Drugs by trial phase (17 distinct, 22 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Ascites
- Breast Neoplasms
- Bronchiectasis
- Carcinoma
- Carcinoma, Ovarian Epithelial
- Cystic Fibrosis
- Diabetes Mellitus, Type 1
- Diabetic Nephropathies
- Fibrosis
- Graft vs Host Disease
- Idiopathic Pulmonary Fibrosis
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- Ovarian Neoplasms
- Peritoneal Neoplasms
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Pulmonary Fibrosis
- Stomach Neoplasms
- Syndrome
- Vascular Diseases
Recent trials (23)
- NCT04971005CollaboratorPhase 2Aug 27, 2021
- NCT02377193CollaboratorPhase 4Sep 1, 2013
- NCT01582048CollaboratorPhase 2Apr 1, 2012
- NCT01504256CollaboratorPhase 2Oct 1, 2011
- NCT01295710Study directorPhase 3Jun 1, 2011
- NCT01295710Lead sponsorPhase 3Jun 1, 2011
- NCT01320020Lead sponsorPhase 1Feb 1, 2011
- NCT01246440CollaboratorPhase 2Jun 1, 2010
- NCT01065246Lead sponsorPhase 2Nov 1, 2009
- NCT00822809Lead sponsorPhase 3Dec 1, 2008
- NCT00522457Lead sponsorPhase 2Jan 1, 2008
- NCT00563836Lead sponsorPhase 2Nov 1, 2007
- NCT00464893Lead sponsorPhase 2Apr 1, 2007
- NCT00452140Lead sponsorPhase 2Mar 1, 2007
- NCT01324934Lead sponsorPhase 3Oct 1, 2006
Details
- Founded
- Grafelfing, DE Jun 1, 2003
- Last known activity
- Aug 27, 2021